Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
about
sameAs
Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceGroup schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial.The 2014 Survey on Living with Chronic Diseases in Canada on Mood and Anxiety Disorders: a methodological overviewInverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.Overrepresentation of unaccompanied refugee minors in inpatient psychiatric care.The POSE study - panic control treatment versus panic-focused psychodynamic psychotherapy under randomized and self-selection conditions: study protocol for a randomized controlled trial.Generalized anxiety disorder in primary care: mental health services use and treatment adequacyTopiramate augmentation in a patient with obsessive-compulsive disorder.A qualitative study of perceived needs and factors associated with the quality of care for common mental disorders in patients with chronic diseases: the perspective of primary care clinicians and patients.Social anxiety disorder in Saudi adolescent boys: Prevalence, subtypes, and parenting style as a risk factorEffect of Beta vulgaris Linn. Leaves Extract on Anxiety- and Depressive-like Behavior and Oxidative Stress in Mice after Acute Restraint StressChanges in temporal attention inhibition following prolonged exposure and sertraline in the treatment of PTSDEffectiveness of In Virtuo Exposure and Response Prevention Treatment Using Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder: A Study Based on a Single-Case Study ProtocolPsychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients.Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savingsA Qualitative Study on Incentives and Disincentives for Care of Common Mental Disorders in Ontario Family Health TeamsIncentives and disincentives for treating of depression and anxiety in Ontario Family Health Teams: protocol for a grounded theory study.Comprehensive neuropsychological evaluation of children and adolescents with sickle cell anemia: a hospital-based sample.Sex and gender considerations in Canadian clinical practice guidelines: a systematic reviewThe reappraisal of benzodiazepines in the treatment of anxiety and related disorders.Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition.Treatment-resistant panic disorder: a systematic review.Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case report and review of the literature.Who Should Transition? Defining a Target Population of Youth with Depression and Anxiety That Will Require Adult Mental Health Care.No role for benzodiazepines in posttraumatic stress disorder? A surplus of certainty despite scarce evidence.Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders.Novel pharmacological treatment strategies for posttraumatic stress disorder.Panic attacks and panic disorder in the American Indian community.Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.Anxiety and Cardiovascular Disease Risk: a Review.Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy.Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?Pharmacokinetic patterns of risperidone-associated adverse drug reactions.The pattern of anxiolytic and hypnotic management by Australian general practice trainees.Utilization of healthcare services among elderly with cognitive impairment no dementia and influence of depression and anxiety: a longitudinal study.Benzodiazepine use associated with co-morbid post-traumatic stress syndrome and depression in older adults seeking services in general medical settings.Prescribing Practices of Quetiapine for Insomnia at a Tertiary Care Inpatient Child and Adolescent Psychiatry Unit: A Continuous Quality Improvement Project.
P2860
Q26774013-03A10F27-112D-470D-B70D-371E053876CAQ26800235-3C356E48-8F2F-4B08-8654-26FFB19DD561Q30819611-21B371E0-B93B-45BA-82B2-78FF1C405CDEQ33552055-333E5650-AE38-4E7C-91B6-CEBA04151B81Q33658933-12993D7F-5928-4F3E-AF25-324A6EA45F8DQ34676776-1AFE573A-F91D-4D07-977C-8DE9F49F6385Q34680866-FF48DA72-1DB9-44D8-AEE4-6F65AB4A6A7CQ35214482-D5FB638E-8C28-4825-9477-702C41C85E95Q35368121-62CB6280-80CB-4E1E-9C86-DBDDA78B3BC0Q35817586-2E9C311E-1E57-4633-825D-2142E3C1A014Q35976177-39281FBE-8F60-499F-AA5C-B163D9B57A75Q36130671-1B3C78B0-CAFC-4204-BA0B-04EB76460642Q36555929-A5E2B75A-FDD9-498D-968D-09190794CB82Q36580446-5BA3D137-A19D-4FE1-9911-DEF40F873D73Q36813518-50F72EEB-CEB7-4E27-98E3-B8AE003306ACQ36995762-4A2D77BE-9438-4AD7-ADC9-519D52EB4852Q37055695-F7A0F522-B3A8-4E5A-89DA-AC5FA0143CBBQ37174306-5DAE8BC0-E31D-4536-A1F9-D8D7AFAE8DE6Q37224936-482BED23-6E96-4F25-A9C0-BBF01F829323Q37453716-B82E42A2-8C35-46BB-B3A9-7E668A526FBAQ37683309-750F674C-6C28-4119-B76B-CDBACE18EF52Q37735894-9EF67BE0-48F1-427E-92DB-4E6AC66C3020Q38252986-8DD325A1-419C-43BD-B901-1963650FE498Q38507142-08FF8149-A22A-45F9-804A-34B59FA78D7DQ38658698-287D10FF-F5FD-4410-8935-9C3F8008E9B8Q38692654-49CBAFA2-BAB6-49AC-AE00-31790A6F5176Q38727564-0F019F85-9E43-4A40-B6F8-9FE775D2B189Q38764291-02F505B4-635C-4CEC-BF3A-C3BAEEF56C71Q38792168-B6911B63-9524-446A-9AF9-385A755DFDBAQ38796437-BB0ED020-7DE7-46C0-A9CB-B99F980372D0Q38813303-8DD3661B-7099-4608-B124-60DFFCC31719Q38825574-2070D68A-282A-4C5D-B075-DE39877DED33Q38994786-27D433AF-11C2-4D84-A0E8-F19F178EBFCFQ39254757-6BF61C2E-5428-44A7-B6F8-B43BA4006FD3Q39388243-4F8B3776-C15D-47EB-A548-F71EB32EBBE5Q39633628-0FED2226-3094-4B84-A78C-00DEF1F66AFBQ39758927-1A3A7C5C-7104-4B35-A3CA-5C92366BD0ACQ39902481-532791B5-0C25-49B8-8EFC-D0A4E35270DEQ40067791-4B1E8D47-411D-4C92-9766-E6387D8E75E3Q41018102-472D8711-438E-4053-BB33-159BCAC7C999
P2860
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Canadian clinical practice gui ...... obsessive-compulsive disorders
@ast
Canadian clinical practice gui ...... obsessive-compulsive disorders
@en
Canadian clinical practice gui ...... obsessive-compulsive disorders
@nl
type
label
Canadian clinical practice gui ...... obsessive-compulsive disorders
@ast
Canadian clinical practice gui ...... obsessive-compulsive disorders
@en
Canadian clinical practice gui ...... obsessive-compulsive disorders
@nl
prefLabel
Canadian clinical practice gui ...... obsessive-compulsive disorders
@ast
Canadian clinical practice gui ...... obsessive-compulsive disorders
@en
Canadian clinical practice gui ...... obsessive-compulsive disorders
@nl
P2093
P2860
P921
P3181
P1433
P1476
Canadian clinical practice gui ...... obsessive-compulsive disorders
@en
P2093
Alain Brunet
Canadian Anxiety Guidelines In ...... anxieux and McGill University
Kevin Kjernisted
Kieron O'Connor
Kiran Rabheru
Martin A Katzman
Martin M Antony
Martine Flament
Melisa Robichaud
Michael Van Ameringen
P2860
P2888
P3181
P356
10.1186/1471-244X-14-S1-S1
P407
P433
P478
14 Suppl 1
P5008
P577
2014-07-02T00:00:00Z
P5875
P6179
1048867495